Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Menne

Showing results (91-100 of 113) with videos related to

Pageof 12
Sort By:
Clinical Kidney Journal|April 13, 2019
Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational studyJan Menne, Yahsou Delmas, Fadi Fakhouri, et al.
Plos One|October 17, 2012
Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndromeJohan M Lorenzen, Jan Menne, Bernhard M W Schmidt, et al.
Kidney International Reports|October 21, 2024
Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 919-928]Jessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
Circulation|August 11, 2004
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failureFerdinand H Bahlmann, Rong Song, Sascha M Boehm, et al.
Kidney International Reports|July 31, 2024
Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum HemorrhageJessica K Kaufeld, Ulf Schönermarck, Lucas Kühne, et al.
Kidney International Reports|May 20, 2024
Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement InhibitionJessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpuraLucas Kühne, Jessica Kaufeld, Linus A Völker, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2017
Chronic Deep Brain Stimulation Decreases Blood Pressure and Sympathetic Nerve Activity in a Drug- and Device-Resistant Hypertensive PatientErin L O'Callaghan, Emma C Hart, Hugh Sims-Williams, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2016
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label TrialFadi Fakhouri, Maryvonne Hourmant, Josep M Campistol, et al.
Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor ModulationKarsten Heusser, Arvo Thöne, Axel Lipp, et al.
Pageof 12

Showing results (91-100 of 113) with videos related to

Sort By:
Pageof 12
Clinical Kidney Journal|April 13, 2019
Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational studyJan Menne, Yahsou Delmas, Fadi Fakhouri, et al.
Plos One|October 17, 2012
Circulating microRNAs in patients with Shiga-Toxin-producing E. coli O104:H4 induced hemolytic uremic syndromeJohan M Lorenzen, Jan Menne, Bernhard M W Schmidt, et al.
Kidney International Reports|October 21, 2024
Erratum to "Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement Inhibition" [<i>Kidney International Reports</i> Volume 9, Issue 4, April 2024, Pages 919-928]Jessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
Circulation|August 11, 2004
Low-dose therapy with the long-acting erythropoietin analogue darbepoetin alpha persistently activates endothelial Akt and attenuates progressive organ failureFerdinand H Bahlmann, Rong Song, Sascha M Boehm, et al.
Kidney International Reports|July 31, 2024
Challenges and Considerations in Managing Thrombotic Microangiopathy and Disseminated Intravascular Coagulation in Postpartum HemorrhageJessica K Kaufeld, Ulf Schönermarck, Lucas Kühne, et al.
Kidney International Reports|May 20, 2024
Features of Postpartum Hemorrhage-Associated Thrombotic Microangiopathy and Role of Short-Term Complement InhibitionJessica K Kaufeld, Lucas Kühne, Ulf Schönermarck, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Alternate-day dosing of caplacizumab for immune-mediated thrombotic thrombocytopenic purpuraLucas Kühne, Jessica Kaufeld, Linus A Völker, et al.
Hypertension (Dallas, Tex. : 1979)|March 1, 2017
Chronic Deep Brain Stimulation Decreases Blood Pressure and Sympathetic Nerve Activity in a Drug- and Device-Resistant Hypertensive PatientErin L O'Callaghan, Emma C Hart, Hugh Sims-Williams, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 26, 2016
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label TrialFadi Fakhouri, Maryvonne Hourmant, Josep M Campistol, et al.
Hypertension (Dallas, Tex. : 1979)|December 3, 2019
Efficacy of Electrical Baroreflex Activation Is Independent of Peripheral Chemoreceptor ModulationKarsten Heusser, Arvo Thöne, Axel Lipp, et al.
Pageof 12